Search Results
ANGLE PLC sees big opportunities in non-invasive prenatal testing
ANGLE PLC opens up potential route to market for Parsortix platform
ANGLE PLC – a small British company changing the world in cancer
ANGLE PLC has opened up "a major market opportunity" with breast cancer partnership
ANGLE PLC submits its flagship Parsortix liquid biopsy diagnostic to the FDA
ANGLE plc's Parsortix device plays critical role in ground-breaking new cancer research
ANGLE PLC's Andrew Newland on 'breakthrough in culturing CTCs'
ANGLE announce first large-scale pharma services contract for Parsortix liquid biopsy
ANGLE PLC's Andrew Newland on 'very exciting' liquid biopsy breakthrough
ANGLE Parsortix Procedure
Angle expects deluge of news in months ahead as Parsortix makes progress
Shares Spotlight - Andrew Newland, CEO of Angle PLC
